Tempus AI received a 510(k) Premarket Notification from the FDA to indicate that the Tempus ECG-AF device was judged “Substantially Equivalent,” according to a notice posted to the FDA site with a decision date of June 21.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM: